These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6142750)

  • 21. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
    Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
    J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.
    Sorbi S; Piacentini S; Amaducci L
    Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences between early and late-onset Alzheimer's disease.
    Iversen LL
    Neurobiol Aging; 1987; 8(6):554-5. PubMed ID: 3431630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Exp Brain Res; 1982; Suppl 5():153-7. PubMed ID: 6129994
    [No Abstract]   [Full Text] [Related]  

  • 25. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.
    Reisine TD; Yamamura HI; Bird ED; Spokes E; Enna SJ
    Brain Res; 1978 Dec; 159(2):477-81. PubMed ID: 215272
    [No Abstract]   [Full Text] [Related]  

  • 26. The temporal lobe in dementia of Alzheimer's type.
    Wilcock GK
    Gerontology; 1983; 29(5):320-4. PubMed ID: 6618185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiology of senile dementia].
    Karobath M
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1803-7. PubMed ID: 2868521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alzheimer's type dementia: recent data].
    Lamour Y; Davous P
    Presse Med; 1983 May; 12(22):1415-20. PubMed ID: 6134279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group.
    DeKosky ST; Harbaugh RE; Schmitt FA; Bakay RA; Chui HC; Knopman DS; Reeder TM; Shetter AG; Senter HJ; Markesbery WR
    Ann Neurol; 1992 Nov; 32(5):625-32. PubMed ID: 1360195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Moroji T; Kosaka K
    Neurosci Lett; 1984 Nov; 52(1-2):73-8. PubMed ID: 6152043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.
    Arai H; Ichimiya Y; Kosaka K; Moroji T; Iizuka R
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):883-90. PubMed ID: 1381103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome.
    Pierotti AR; Harmar AJ; Simpson J; Yates CM
    Neurosci Lett; 1986 Jan; 63(2):141-6. PubMed ID: 2869457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic deficit in frontal cerebral cortex in Alzheimer's disease is age dependent.
    Rossor MN; Iversen LL; Johnson AJ; Mountjoy CQ; Roth M
    Lancet; 1981 Dec 19-26; 2(8260-61):1422. PubMed ID: 6118790
    [No Abstract]   [Full Text] [Related]  

  • 34. Biological markers in mental disorders: post-mortem studies.
    Rossor M
    J Psychiatr Res; 1984; 18(4):457-65. PubMed ID: 6150994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 36. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
    Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
    Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease.
    Esiri MM; Pearson RC; Steele JE; Bowen DM; Powell TP
    J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):161-5. PubMed ID: 2313304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase.
    Fu AL; Li Q; Dong ZH; Huang SJ; Wang YX; Sun MJ
    Neurosci Lett; 2004 Sep; 368(3):258-62. PubMed ID: 15364407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.